Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


Ceftazidime pentahydrate


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-B0593A-500MG 500 mg 276,00 234,60 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

GR20263 pentahydrate
Ceftazidime pentahydrate (GR20263 pentahydrate) is a third generation cephalosporin administered intravenously or intramuscularly. Ceftazidime pentahydrate has a broad spectrum of in vitro activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime pentahydrate is particularly active against Enterobacteriaceae (including beta-lactamase-positive strains) and is resistant to hydrolysis by most beta-lactamases.

Category Biochemicals
Supplier MedChem Express
Application COVID-19-immunoregulation
Regulatory Status RUO
Grade Clinical information: Launched
Purity 98.76%
Molecular Formula C22H32N6O12S2
Molecular Weight 636.65
CAS-Number [78439-06-2]
Storage Conditions Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland